ArticleClinical cancer research : an official journal of the American Association for Cancer Research2019

Glycogen Synthase Kinase-3 Inhibition Sensitizes Pancreatic Cancer Cells to Chemotherapy by Abrogating the TopBP1/ATR-Mediated DNA Damage Response.

Li Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.